Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08BFF
|
|||
Drug Name |
US10179791, Compound 296
|
|||
Synonyms |
SCHEMBL10265363; BDBM321333; US10179791, Compound 296
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H27ClFNO3S
|
|||
Canonical SMILES |
CCC1=C(C(=CC=C1)Cl)CSC2=C(C3=C(C=C2)C4(CCN(CC4)CCC(=O)O)CO3)F
|
|||
InChI |
1S/C24H27ClFNO3S/c1-2-16-4-3-5-19(25)17(16)14-31-20-7-6-18-23(22(20)26)30-15-24(18)9-12-27(13-10-24)11-8-21(28)29/h3-7H,2,8-15H2,1H3,(H,28,29)
|
|||
InChIKey |
QTCUMVXBAZTPSZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target Info | Inhibitor | [1] |
Target's Patent Info | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target's Patent Info | [1] | |
KEGG Pathway | Sphingolipid signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Pathway Interaction Database | S1P3 pathway | |||
Sphingosine 1-phosphate (S1P) pathway | ||||
Reactome | G alpha (i) signalling events | |||
Lysosphingolipid and LPA receptors | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Spiro-cyclic amine derivatives as S1P modulators. US10179791. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.